| 2611 |
TETRACYCLINE HYDROCHLORIDE |
TETRACYCLINE HYDROCHLORIDE 250 MG |
CAPSULE |
BOTTLE |
IN INFECTIONS PRODUCED BY SUSCEPTIBLE STRAINS OF MYCOPLASMA, CHLAMYDIA, RICKETTSIAE AND BACTERIAL INFECTIOUS DISEASES INCLUDING ROCKY MOUNTAIN SPOTTED FEVER, MURINE TYPHUS, RECRUDESCENT EPIDEMIC TYPHUS, SCRUB TYPHUS, Q FEVER, LYMPHOGRANULOMA VENEREUM, PSITTACOSIS TULARAEMIA AND BRUCELLOSIS. |
NULL |
VIENGCHALEUN PHARMA IMPORT-EXPORT COMPANY |
LIAONING HUARUI UNITED PHARMACEUTICAL CO.,LTD |
CHINA |
CERTIFICATE RELEASED |
05 I 3288/09 |
08-APR-2024 |
07-APR-2027 |
View |
| 2612 |
TRIVITAMINS B |
VITAMIN B1 12.5MG, VITAMIN B6 12.5MG, VITAMIN B12 125MCG |
FILM COATED TABLET |
BLISTERPACK |
USED IN THE TREATMENT OF VITAMIN B1, VITAMIN B6 AND VITAMIN B12. ALSO USED FOR MONONEUROPATHY OR POLYNEURITIS CAUSED BY DIFFERENT OF ETIOPATHOGENESIS |
NULL |
VIENGCHALEUN PHARMA IMPORT-EXPORT COMPANY |
LIAONING HUARUI UNITED PHARMACEUTICAL CO.,LTD |
CHINA |
CERTIFICATE RELEASED |
12 I 2677/05 |
28-APR-2023 |
27-APR-2026 |
View |
| 2613 |
VEJAR - VK |
PHENOXYMETHYL PENICILLIN POTASSIUM 400.000 IU |
TABLET |
BLISTERPACK |
TREATMENT OF UPPER RESPIRATORY TRACT INFECTION, TREATMENT OF PNEUMOCOCCAL, STREPTOCOCCI AND STAPHYLOCOCCAL INFECTION AND INFECTION OF OROPHARYNX CAUSIED BY SUSCEPTIBLE MICROORGANISMS. |
NULL |
VIENGCHALEUN PHARMA IMPORT-EXPORT COMPANY |
SINOPHARM WEIQIDA PHARMACEUTICAL CO.,LTD |
CHINA |
CERTIFICATE RELEASED |
09 I 4092/15 |
23-AUG-2022 |
22-AUG-2025 |
View |
| 2614 |
VELLTAXIM-1 |
CEFOTAXIME SODIUM (STERILE) USP EQ.TO CEFOTAXIME 1000 MG |
POWDER FOR SOLUTION FOR INJECTION |
VIAL |
INFECTION OF THE LOWER RESPIRATORY TRACT, INFECTION OF THE KIDNEY AND URNARY TRACT, INFECTION OF THE SKIN AND SOFT TISSUE, GENITAL INFECTION, INTRA-ABDOMINAL INFECTION. |
NULL |
VIENGCHALEUN PHARMA IMPORT-EXPORT COMPANY |
VELLINTON HEALTHCARE |
INDIA |
CERTIFICATE RELEASED |
11 I 5656/23 |
23-NOV-2023 |
22-Nov-2026 |
View |
| 2615 |
VELOM-40 |
OMEPRAZOLE SODIUM 40 MG |
SOLUTION FOR INJECTION |
VIAL |
TREATMENT OF DUODENAL ULCER, PREVENTION OF RELAPSE OF DUODENAL ULCER, TREATMENT OF GASTRIC ULCER, PREVENTION OF RELAPSE OF GASTRIC ULCER. |
NULL |
VIENGCHALEUN PHARMA IMPORT-EXPORT COMPANY |
VELLINTON HEALTHCARE |
INDIA |
CERTIFICATE RELEASED |
11 I 5657/23 |
23-NOV-2023 |
22-Nov-2026 |
View |
| 2616 |
VELXONE-1 |
CEFTRIAXONE SODIUM (STERILE) USP EQ.TO CEFTRIAXONE 1000 MG |
POWDER FOR SOLUTION FOR INJECTION |
VIAL |
BACTERIAL MENINGITIS, COMMUNITY ACQUIRED PNEUMONIA, HOSPITAL ACQUIRED PNEUMONIA, ACUTE OTITIS MEDIA, GONORRHOEA, SYPHILIS, BACTERIAL ENDOCARDITIS |
NULL |
VIENGCHALEUN PHARMA IMPORT-EXPORT COMPANY |
VELLINTON HEALTHCARE |
INDIA |
CERTIFICATE RELEASED |
11 I 5658/23 |
23-NOV-2023 |
22-Nov-2026 |
View |
| 2617 |
VITAMIN B1 |
VITAMIN B1 10MG |
TABLET |
BOTTLE |
MAINLY USED IN THE TREATMENT OF VITAMIN B1 DEFICIENCY AND USED IN THE SUPPLEMENTARY. |
NULL |
VIENGCHALEUN PHARMA IMPORT-EXPORT COMPANY |
HUAZHONG PHARMACEUTICAL CO.,LTD |
CHINA |
CERTIFICATE RELEASED |
12 I 2698/05 |
28-APR-2023 |
27-APR-2026 |
View |
| 2618 |
VITAMIN B1 |
THIAMINE 100MG/ML |
SOLUTION FOR INJECTION |
AMPOULES |
USED IN THE TREATMENT OF BERIBERI CAUSED BY DEFICIENCY OF VITAMIN B1 AND CEREBROSIS OF WERNICKE. ALSO USED IN SUPPLEMENTARY TREATMENT OF NEURITIS AND DYSPEPSIA |
NULL |
VIENGCHALEUN PHARMA IMPORT-EXPORT COMPANY |
SHANGHAI PUJIN LINZHOU PHARMACEUTICAL CO.,LTD |
CHINA |
CERTIFICATE RELEASED |
12 I 2696/05 |
08-APR-2024 |
07-APR-2027 |
View |
| 2619 |
VITAMIN B12 |
CYANOCOBALAMIN 1000 MCG/ML |
SOLUTION FOR INJECTION |
AMPOULES |
MAINLY USED IN THE TREATMENT OF MEGALOBLASTIC ANEMIA AND USED IN THE SUPPLEMENTARY TREATMENT OF NEURITIS |
NULL |
VIENGCHALEUN PHARMA IMPORT-EXPORT COMPANY |
SHANGHAI PUJIN LINZHOU PHARMACEUTICAL CO.,LTD |
CHINA |
CERTIFICATE RELEASED |
12 I 2719/05 |
03-MAR-2025 |
02-MAR-2030 |
View |
| 2620 |
VITAMIN B12 CAPLETS |
VITAMIN B12 25 MCG |
FILM COATED TABLET |
ALUMINUM FOIL & BOTTLE |
USED IN THE TREATMENT OF MEGALOBLASTIC ANAEMIA. |
NULL |
VIENGCHALEUN PHARMA IMPORT-EXPORT COMPANY |
SHANXI SHUGUANG PHARMACEUTICAL CO.,LTD |
CHINA |
CERTIFICATE RELEASED |
09 I 4804/19 |
26-SEP-2022 |
25-SEP-2025 |
View |
